Your monthly digest of professional document developments.

The board has approved a new position statement on the use of ketamine in the management of chronic non-cancer pain

Important information on changes to the design of salbutamol (Ventolin) metered dose inhalers (MDIs/‘puffers’) in Australia.

Dr Chris Cokis succeeds Dr Vanessa Beavis as ANZCA President in today's handover ceremony

We’re seeking expressions of interest from FPM fellows to replace the current faculty representative on the ANZCA Information and Communications Technology (ICT) Governance Committee.

Changes to item mapping in the MBS affecting both pain medicine and anaesthesia will come into effect on 1 March 2022.

Our Effective Management of Anaesthetic Crises (EMAC) Course Sub-committee is looking for two new members. Applications close Friday 30 April 2021.

New this month: Safety alerts; mass changeover of neural connectors; webAIRS recognition; new Clinical Care Standard; and Safer Care Vic event.

ANZCA has published a joint statement with diabetes groups in Australia and NZ on periprocedural diabetic ketoacidosis and SGLT2i use.

The college has provided a 2022 election priorities statement to the major political parties.